本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

78.01
+1.211.58%
盘后:78.010.00000.00%19:30 EST
成交量:354.72万
成交额:2.76亿
市值:151.96亿
市盈率:-25.70
高:78.25
开:76.45
低:75.99
收:76.80
52周最高:93.42
52周最低:62.50
股本:1.95亿
流通股本:1.63亿
量比:1.88
换手率:2.18%
股息:- -
股息率:- -
每股收益(TTM):-3.0358
每股收益(LYR):-3.7850
净资产收益率:-1789.67%
总资产收益率:-13.97%
市净率:-5.83
市盈率(LYR):-20.61

数据加载中...

2026/11/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/10/29

重要事件披露

Form 8-K - Current report
2026/10/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/10/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/10/13

重要事件披露

Form 8-K - Current report
2026/09/01

重要事件披露

Form 8-K - Current report
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

重要事件披露

Form 8-K - Current report
2026/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/03

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/23

重要事件披露

Form 8-K - Current report
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report